Benzinga | Aug 12, 2020 04:23PM EDT

TELA Bio Q2 EPS $(0.53) Beats $(0.59) Estimate, Sales $3.51M Beat $1.93M Estimate

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.59) by 10.17 percent. This is a 98.04 percent increase over losses of $(27.06) per share from the same period last year. The company reported quarterly sales of $3.51 million which beat the analyst consensus estimate of $1.93 million by 81.71 percent. This is a 6.18 percent increase over sales of $3.30 million the same period last year.